Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema - Wikidata - wikimedia - TriplyDB

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema

http://www.wikidata.org/entity/Q24240165

about

Anti-vascular endothelial growth factor for diabetic macular oedema Interventions for age-related visual problems in patients with stroke Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy Anti-vascular endothelial growth factor for proliferative diabetic retinopathy Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy Protocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trials The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review.Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.Optimal treatment of diabetic retinopathy.Diabetic retinopathy - An update.A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy.Wnting out ocular neovascularization: using nanoparticle delivery of very-low density lipoprotein receptor extracellular domain as Wnt pathway inhibitor in the retina.Anthrax lethal toxin suppresses high glucose induced VEGF over secretion through a post-translational mechanism.Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema.Effect of Bak Foong Pills on the expression of β-amyloid in rat retina with optic nerve transection.Intravitreal Bevacizumab with or without Triamcinolone for Refractory Diabetic Macular Edema: Long-term Results of a Clinical Trial Anti-VEGF (vascular endothelial growth factor) drugs in diabetic macular oedema.

P2860

Q24193083-4DD8D0D5-D0A8-4CB8-85C4-57A8A201D57B Q24201153-7AD369C6-E70C-4253-88A0-F5B2C07FFC2D Q24202071-C138F0D1-C00C-4781-8273-D6F354AF30EC Q24235325-221DA970-6C8C-47C5-911C-8FBA592AE899 Q24236189-CC0BF8B2-8C40-486C-8D52-7E3C6DC7706A Q28565180-74A8A7E0-C9D2-4633-AB36-051CEE361078 Q28680651-EB94CCD3-C8DA-4E9F-B451-2B3A13BAEB81 Q34378757-5AEA172D-1FE1-4C37-B20A-EFE881935CE1 Q34558187-593E6E6A-1B0B-4D1B-963C-1A5CC62B879B Q34693503-1DC9F9AE-B513-4890-8F72-EFA2808E2590 Q34957902-3192E4B7-17FC-4921-A2B6-7A0A82BAF8F4 Q35180490-99775515-27A8-43EC-8EBB-B2DB061E6D1A Q35597138-D537C245-670A-4C96-8BC2-B82FD985EF33 Q35691890-D535858A-7FD3-46E9-80D0-766CA2E66A2F Q36339514-70EDCA53-A39C-44CD-992E-5F024283457F Q36391018-668ABFFB-7056-4E44-802B-988BEF5503DC Q42012437-72C997CB-4FF2-452C-BB6E-87F931FD870E Q42091540-CFAA8BA0-E98A-4085-A9C5-0F4C079ABDD2 Q42907212-6D6D5E66-0C0A-4885-ABAB-BE7D9456B73B

P2860

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema

http://www.wikidata.org/entity/Q24240165

description

1996 nî lūn-bûn

@nan

1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Antiangiogenic therapy with an ...... es for diabetic macular oedema

@ast

Antiangiogenic therapy with an ...... es for diabetic macular oedema

@en

Antiangiogenic therapy with an ...... es for diabetic macular oedema

@en-gb

Antiangiogenic therapy with an ...... es for diabetic macular oedema

@nl

type

label

Antiangiogenic therapy with an ...... es for diabetic macular oedema

@ast

Antiangiogenic therapy with an ...... es for diabetic macular oedema

@en

Antiangiogenic therapy with an ...... es for diabetic macular oedema

@en-gb

Antiangiogenic therapy with an ...... es for diabetic macular oedema

@nl

prefLabel

Antiangiogenic therapy with an ...... es for diabetic macular oedema

@ast

Antiangiogenic therapy with an ...... es for diabetic macular oedema

@en

Antiangiogenic therapy with an ...... es for diabetic macular oedema

@en-gb

Antiangiogenic therapy with an ...... es for diabetic macular oedema

@nl

P1433

Q24240165-DDBCAECC-5A6C-46CD-8EE5-C089F18434DF

P1476

Q24240165-E49EF2D1-E3DC-43EF-91FA-30B95172226B

P2093

Q24240165-71D04D05-EF98-4EAB-AB68-7D3C25C8CB90

Q24240165-F12E75C5-7DAC-4E72-9FDD-0DA95441FAFA

P2860

Q24240165-0393D038-5DFF-4D43-B83C-BCDB2FCE472D

Q24240165-11AD9E79-DF9C-4A1C-89B1-6282FE1BE2AD

Q24240165-180CEC62-3130-4A5F-B370-BCEEB9379414

Q24240165-1AD49C49-B269-4269-866D-CE3A9D28B6DC

Q24240165-31B3A4AB-467E-43E0-8F19-DD27F5AE670D

Q24240165-31BA9F6F-834F-4419-81A2-30C9C3C2CB6E

Q24240165-6145305F-B93B-451C-A7A3-6B741A3814AD

Q24240165-66860555-1FD1-4113-91C5-7DD395B9F65A

Q24240165-97E09544-CD93-48AC-940F-2567808F120A

Q24240165-997BA1DD-32DA-46C3-9B63-226A06CF5FEF

P31

Q24240165-3277DE33-F3EA-4AE6-936C-B3EFDCF2B80F

Q24240165-53eea56f-c185-418c-9d7a-17300e2bf70a

P356

Q24240165-DA229FDA-02C7-487D-A33F-7F54D90402C1

P50

Q24240165-7B4F04A0-44BD-4C2E-91D1-7D4A832550E2

P577

Q24240165-9676723A-D041-4DB9-8CA7-58B4B7608F24

P698

Q24240165-8EEEE9EE-1815-4BCE-B6EB-7C96C1BC9AFF

P921

Q24240165-DA2B7C50-C56B-4EAF-B731-8089A76EFF4E

P356

14651858.CD007419.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Antiangiogenic therapy with an ...... es for diabetic macular oedema

@en

P2093

Francesca Menchini

http://www.w3.org/2001/XMLSchema#string

Mariacristina Parravano

http://www.w3.org/2001/XMLSchema#string

P2860

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

The importance of fluorescein angiography in planning laser treatment of diabetic macular edema.

Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.

Allowing for uncertainty due to missing data in meta-analysis--part 1: two-stage methods.

Risk factors for diffuse and focal macular edema.

A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema

Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.

Interventions for diabetic macular oedema: a systematic review of the literature.

Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.

P31

scholarly article

P356

10.1002/14651858.CD007419.PUB2

http://www.w3.org/2001/XMLSchema#string

P50

P577

1996-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19821414

http://www.w3.org/2001/XMLSchema#string

P921